A preliminary study evaluated the effects of this new multicomponent food supplement alongside antihistamine therapy in children with seasonal allergic rhinitis (SAR)
[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Saxena R., Hivert M.F., Langenberg C., Tanaka T., Pankow J.S., Vollenweider P., Lyssenko V., Bouatia-Naji N., Dupuis J., Jackson A.U., et al
For orforglipron you only reported the numbers of serious and severe events (which is why the %s are very small)
doi: 10.1038/srep24229 136 WuWHuZQinYDongJDaiJLuCet al
After review of additional data, the 2023 ACC/AHA Guidelines for the Management of Patients with Chronic Coronary Disease published a strong (Class 1, LoE A) recommendation for the use of GLP-1 RA with proven cardiovascular benefits in patients with diabetes and chronic coronary disease to reduce the risk of MACE